Victor Appay is a research director at the INSERM, and co-head of the “Vulnerability and Ageing of the Immune System” team within the ImmunoConcept unit of the Bordeaux University.
After receiving an engineer diploma in Biotechnology at the Ecole Superieure de Biotechnologie de Strasbourg (France) in 1997, Victor joined the department of Prof Andrew McMichael at the University of Oxford (England) where he obtained a PhD in Immunology in 2001 under the supervision of Prof Sarah Rowland-Jones. Following postdoctoral experiences both in Oxford and Lausanne (Switzerland), he established his research team in Paris (France) in 2005, before moving to Bordeaux in 2020.
The study of cellular immunity has been the central theme of his research for more than 25 years. His work has initially focused on the characterization of human T cells in various infectious contexts, particularly HIV-1 infection. For two decades, he has concentrated increasing efforts on the study of immune ageing and vaccination in the older population, with the aim to provide advanced understanding in the emerging field of immunogerontology
